These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8355780)

  • 21. Duchenne muscular dystrophy.
    Gorospe JR; Hoffman EP
    Curr Opin Rheumatol; 1992 Dec; 4(6):794-800. PubMed ID: 1457273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
    Abmayr S; Gregorevic P; Allen JM; Chamberlain JS
    Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
    Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M
    Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy for Duchenne dystrophy.
    Engel AG
    Ann Neurol; 1993 Jul; 34(1):3-4. PubMed ID: 8517677
    [No Abstract]   [Full Text] [Related]  

  • 25. Functional enhancement of skeletal muscle by gene transfer.
    Gregorevic P; Chamberlain JS
    Phys Med Rehabil Clin N Am; 2005 Nov; 16(4):875-87, vii-viii. PubMed ID: 16214049
    [No Abstract]   [Full Text] [Related]  

  • 26. Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.
    Zhou GQ; Xie HQ; Zhang SZ; Yang ZM
    Chin Med J (Engl); 2006 Aug; 119(16):1381-91. PubMed ID: 16934185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The physiological evaluation of gene therapies of dystrophin-deficient muscles.
    Gillis JM; Deconinck N
    Adv Exp Med Biol; 1998; 453():411-6; discussion 417. PubMed ID: 9889852
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice.
    Ragot T; Vincent N; Chafey P; Vigne E; Gilgenkrantz H; Couton D; Cartaud J; Briand P; Kaplan JC; Perricaudet M
    Nature; 1993 Feb; 361(6413):647-50. PubMed ID: 8437625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Can muscular dystrophy be treated?].
    Somer H
    Duodecim; 1992; 108(6):575-7. PubMed ID: 1366117
    [No Abstract]   [Full Text] [Related]  

  • 30. [Development of new therapy on muscular dystrophy].
    Takeda S
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1154-6. PubMed ID: 12235824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-efficiency plasmid gene transfer into dystrophic muscle.
    Gollins H; McMahon J; Wells KE; Wells DJ
    Gene Ther; 2003 Mar; 10(6):504-12. PubMed ID: 12621454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dystrophin gene expression in patients with Duchenne muscular dystrophy after myoblast transplantation].
    Shishkin SS; Terekhov SM; Krokhina TB; Shakhovskaia NI; Podobedova AN; Linnaia GF; Tarasov VI; Ovchinnikov VI; Krakhmaleva IN; Zakharov SF; Ershova ES; Limborskaia SA; Pogoda TV; Zotikov EA; Kut'ina RM; Tarksh MA; Sukhorukov VS; Gerasimova NL
    Genetika; 2001 Aug; 37(8):1104-11. PubMed ID: 11642111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipofection of a cDNA plasmid containing the dystrophin gene lowers intracellular free calcium and calcium leak channel activity in mdx myotubes.
    McCarter GC; Denetclaw WF; Reddy P; Steinhardt RA
    Gene Ther; 1997 May; 4(5):483-7. PubMed ID: 9274726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Full-length dystrophin gene transfer to the mdx mouse in utero.
    Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
    Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular targets to treat muscular dystrophies.
    Kinter J; Sinnreich M
    Swiss Med Wkly; 2014 Feb; 144():w13916. PubMed ID: 24554202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. More deletions in the 5' region than in the central region of the dystrophin gene were identified among Filipino Duchenne and Becker muscular dystrophy patients.
    Cutiongco EM; Padilla CD; Takenaka K; Yamasaki Y; Matsuo M; Nishio H
    Am J Med Genet; 1995 Nov; 59(2):266-7. PubMed ID: 8588598
    [No Abstract]   [Full Text] [Related]  

  • 37. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.
    Harper SQ; Hauser MA; DelloRusso C; Duan D; Crawford RW; Phelps SF; Harper HA; Robinson AS; Engelhardt JF; Brooks SV; Chamberlain JS
    Nat Med; 2002 Mar; 8(3):253-61. PubMed ID: 11875496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human dystrophin gene transfer: genetic correction of dystrophin deficiency.
    Dickson G; Dunckley M
    Mol Cell Biol Hum Dis Ser; 1993; 3():283-302. PubMed ID: 8111543
    [No Abstract]   [Full Text] [Related]  

  • 39. [Deletion analysis of the dystrophin gene in patients with Duchenne's muscular dystrophy in Tajikistan].
    Odinokova ON; Puzyrev VP; Radzhabaliev ShF; Rakhmonov RA
    Genetika; 1996 Oct; 32(10):1392-5. PubMed ID: 9091412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current state and prospects for gene therapy of Duchenne muscular dystrophy in the world and in Russia].
    Baranov VS; Baranov AN; Zelenin AV
    Genetika; 2001 Aug; 37(8):1046-54. PubMed ID: 11642103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.